For: | Ryu DG, Kim HW, Park SB, Kang DH, Choi CW, Kim SJ, Nam HS. Assessment of disease activity by fecal immunochemical test in ulcerative colitis. World J Gastroenterol 2016; 22(48): 10617-10624 [PMID: 28082814 DOI: 10.3748/wjg.v22.i48.10617] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v22/i48/10617.htm |
Number | Citing Articles |
1 |
Makoto Naganuma, Taku Kobayashi, Masanao Nasuno, Satoshi Motoya, Shingo Kato, Katsuyoshi Matsuoka, Ryota Hokari, Chikako Watanabe, Hirotsugu Sakamoto, Hironori Yamamoto, Makoto Sasaki, Kenji Watanabe, Hideki Iijima, Yutaka Endo, Hitoshi Ichikawa, Keiji Ozeki, Satoshi Tanida, Nobuhiro Ueno, Mikihiro Fujiya, Minako Sako, Ken Takeuchi, Shinya Sugimoto, Takayuki Abe, Toshifumi Hibi, Yasuo Suzuki, Takanori Kanai. Significance of Conducting 2 Types of Fecal Tests in Patients With Ulcerative Colitis. Clinical Gastroenterology and Hepatology 2020; 18(5): 1102 doi: 10.1016/j.cgh.2019.07.054
|
2 |
Ji Young Chang, Jae Hee Cheon. Fecal Immunochemical Test and Fecal Calprotectin Measurement Are Noninvasive Monitoring Tools for Predicting Endoscopic Activity in Patients with Ulcerative Colitis. Gut and Liver 2018; 12(2): 117 doi: 10.5009/gnl17445
|
3 |
Cong Dai, Min Jiang, Ming‐Jun Sun, Qin Cao. Fecal immunochemical test for predicting mucosal healing in ulcerative colitis patients: A systematic review and meta‐analysis. Journal of Gastroenterology and Hepatology 2018; 33(5): 990 doi: 10.1111/jgh.14121
|
4 |
Pontus Karling, David Lundgren, Vincy Eklöf, Richard Palmqvist, Johan Hultdin. Improved monitoring of inflammatory activity in patients with ulcerative colitis by combination of faecal tests for haemoglobin and calprotectin. Scandinavian Journal of Clinical and Laboratory Investigation 2019; 79(5): 341 doi: 10.1080/00365513.2019.1622148
|
5 |
Hirotaka Shimizu, Ryo Ebana, Takahiro Kudo, Takuro Sato, Tomoko Hara, Kenji Hosoi, Masaaki Usami, Masashi Yoshida, Ichiro Takeuchi, Hiroshi Nakase, Itaru Iwama, Katsuhiro Arai, Toshiaki Shimizu. Both fecal calprotectin and fecal immunochemical tests are useful in children with inflammatory bowel disease. Journal of Gastroenterology 2022; 57(5): 344 doi: 10.1007/s00535-022-01856-w
|
6 |
Mindy Winghin Lee, Jonathan S. Pourmorady, Loren Laine. Use of Fecal Occult Blood Testing as a Diagnostic Tool for Clinical Indications: A Systematic Review and Meta-Analysis. American Journal of Gastroenterology 2020; 115(5): 662 doi: 10.14309/ajg.0000000000000495
|
7 |
Natsuki Ishida, Tomohiro Higuchi, Takahiro Miyazu, Satoshi Tamura, Shinya Tani, Mihoko Yamade, Moriya Iwaizumi, Yasushi Hamaya, Satoshi Osawa, Takahisa Furuta, Ken Sugimoto. C-reactive protein is superior to fecal biomarkers for evaluating colon-wide active inflammation in ulcerative colitis. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-90558-z
|
8 |
Natsuki Ishida, Satoshi Tamura, Takahiro Miyazu, Shinya Tani, Mihoko Yamade, Moriya Iwaizumi, Yasushi Hamaya, Satoshi Osawa, Takahisa Furuta, Ken Sugimoto. Comparison between Prostaglandin E-major urinary metabolite and C-reactive protein levels to reflect endoscopic scores in patients with ulcerative colitis. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-95761-6
|
9 |
Pernille Thordal Larsen, Susanne Fogh Jørgensen, Sisse Helle Njor. Colorectal cancer screening participation among citizens not recommended to be screened: a cohort study. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02331-9
|
10 |
Monica State, Lucian Negreanu, Theodor Voiosu, Andrei Voiosu, Paul Balanescu, Radu Bogdan Mateescu. Surrogate markers of mucosal healing in inflammatory bowel disease: A systematic review. World Journal of Gastroenterology 2021; 27(16): 1828-1840 doi: 10.3748/wjg.v27.i16.1828
|
11 |
Dae Gon Ryu, Hyung Wook Kim, Su Bum Park, Dae Hwan Kang, Cheol Woong Choi, Su Jin Kim, Hyeong Seok Nam. Clinical implications of fecal calprotectin and fecal immunochemical test on mucosal status in patients with ulcerative colitis. Medicine 2019; 98(36): e17080 doi: 10.1097/MD.0000000000017080
|
12 |
Natsuki Ishida, Kiichi Sugiura, Takahiro Miyazu, Satoshi Tamura, Satoshi Suzuki, Shinya Tani, Mihoko Yamade, Moriya Iwaizumi, Yasushi Hamaya, Satoshi Osawa, Takahisa Furuta, Ken Sugimoto. Prostaglandin E-Major Urinary Metabolite Predicts Relapse in Patients With Ulcerative Colitis in Clinical Remission. Clinical and Translational Gastroenterology 2020; 11(12): e00289 doi: 10.14309/ctg.0000000000000289
|
13 |
Signe Bülow Therkildsen, Pernille Thordal Larsen, Sisse Helle Njor. Screening participants with inflammatory bowel disease or high colorectal cancer risk in Denmark: a cohort study. Journal of Public Health Policy 2024; doi: 10.1057/s41271-024-00523-z
|
14 |
Hsu-Heng Yen, Mei-Wen Chen, Yu-Yao Chang, Hsuan-Yuan Huang, Tsui-Chun Hsu, Yang-Yuan Chen. Predictive values of stool-based tests for mucosal healing among Taiwanese patients with ulcerative colitis: a retrospective cohort analysis. PeerJ 2020; 8: e9537 doi: 10.7717/peerj.9537
|
15 |
Natsuki Ishida, Masanao Kaneko, Yusuke Asai, Takahiro Miyazu, Satoshi Tamura, Shinya Tani, Mihoko Yamade, Moriya Iwaizumi, Yasushi Hamaya, Satoshi Osawa, Takahisa Furuta, Ken Sugimoto. Effect of disease duration on fecal biomarkers in ulcerative colitis: a prospective cohort study. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02502-8
|
16 |
Patricia Latorre Añó, Jorge Torrente Sánchez, Amparo Almudena Pérez Ibañez, Jose María Tenias Burillo, Nadia Paloma Moreno Sánchez, Antonio López-Serrano, Eduardo Moreno Osset, Julián Murado Pardo, José María Paredes. Fecal immunochemical test for haemoglobin versus fecal calprotectin to monitoring endoscopic activity in inflammatory bowel disease. Revista Española de Enfermedades Digestivas 2023; doi: 10.17235/reed.2023.9536/2023
|